SCHEMBL19642973

SCHEMBL19642973

CC/C=C/CCCCCCCC/C=C/CCCC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.56
TRPV1 Q8NER1 1/20 0.56
F7 P08709 4/20 0.54
F3 P13726 4/20 0.54
MAPT P10636 4/20 0.48
PPARG P37231 4/20 0.48
PPARD Q03181 4/20 0.48
PPARA Q07869 4/20 0.48
ALDH1A1 P00352 3/20 0.48
CYP19A1 P11511 3/20 0.48
BLM P54132 3/20 0.48
KMT2A Q03164 3/20 0.48
HSD17B10 Q99714 3/20 0.48
MEN1 O00255 2/20 0.48
LMNA P02545 2/20 0.48
CYP3A4 P08684 2/20 0.48
ALOX15 P16050 2/20 0.48
PTGS1 P23219 2/20 0.48
RECQL P46063 2/20 0.48
TDP1 Q9NUW8 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15467057 1.00 FAAH (0.56) FAAHTRPV1F7F3MAPT
SCHEMBL29494567 1.00 FAAH (0.56) FAAHTRPV1F7F3MAPT
SCHEMBL9844632 1.00 FAAH (0.56) FAAHTRPV1F7F3MAPT
SCHEMBL29494563 1.00 FAAH (0.56) FAAHTRPV1F7F3MAPT
SCHEMBL2371655 1.00 FAAH (0.56) FAAHTRPV1F7F3MAPT
SCHEMBL15556087 1.00 FAAH (0.56) FAAHTRPV1F7F3MAPT
SCHEMBL860470 1.00 FAAH (0.56) FAAHTRPV1F7F3MAPT
SCHEMBL860471 1.00 FAAH (0.56) FAAHTRPV1F7F3MAPT
SCHEMBL960733 0.97 FAAH (0.52) FAAHTRPV1F7F3MAPT
SCHEMBL25433701 0.94 FAAH (0.64) FAAHTRPV1F7F3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12060323-B2 6-hydroxy-3-hexenyl alkoxymethyl ether compound and a process for preparing a 3,13-octadecadien-1-ol compound from the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-08-13 US disclosed
US-20230312454-A1 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-10-05 US disclosed
EP-3978465-B1 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME SHINETSU CHEMICAL CO (JP) 2023-06-14 EP disclosed
US-20220106252-A1 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-04-07 US disclosed
WO-2017205751-A1 IMPROVED INSECT CONTROL STRATEGIES UTILIZING PHEROMONES AND RNAI PROVIVI, INC. (US) 2017-11-30 WO disclosed
US-20150349259-A1 PROCESS OF PRODUCING AND APPLICATIONS OF THREE COMPONENT BENZO[1,2-B:4,5-B] DITHIOPHENE-THIENOTHIOPHENE RANDOMLY SUBSTITUTED POLYMERS FOR ORGANIC SOLAR CELLS PHILLIPS 66 COMPANY (US) 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12060323-B2 6-hydroxy-3-hexenyl alkoxymethyl ether compound and a process for preparing a 3,13-octadecadien-1-ol compound from the same CYP8B1, CYP2E1, OXER1 FAAH 87/4885TRPV1 2509/4885F7 1817/4885
US-20230312454-A1 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME CYP8B1, CYP2E1, OXER1 FAAH 56/4885TRPV1 2545/4885F7 1780/4885
US-20220106252-A1 6-HYDROXY-3-HEXENYL ALKOXYMETHYL ETHER COMPOUND AND A PROCESS FOR PREPARING A 3,13-OCTADECADIEN-1-OL COMPOUND FROM THE SAME CYP8B1, OXER1, CYP2E1 FAAH 138/4885TRPV1 2324/4885F7 1522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.